comprehensive -WSS

comprehensive

author：hotspot 2025-09-07 06:39:40 - browse：687

Enticed by the immense market opened by GLP-1 weight loss drugs Wegovy and Zepbound, a handful of biotech companies are trying to develop next-generation, longer-lasting therapies based on a very different approach: RNA interference.

This Nobel Prize-winning science works by degrading the biological blueprints that RNA use to make proteins — without the genetic instructions, the troublesome proteins are never made and the gene is essentially muted.

If the companies succeed, it would be a significant shift in the obesity treatment revolution, away from weekly drugs targeting hormones to medications that could be given much less frequently — twice a year or even less — and pinpoint genetic contributors to weight.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily coverage and analysis of the biotech sector — by subscribing to STAT+.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Guidelines to prevent youth baseball injuries need more muscle
Next article： A new deal aims to ramp up use of AI in rehab care decisions

Wikipedia

WSS

Listen: BridgeBio's big week & Lilly's Alzheimer's data

Study: Misdiagnosis causes 800,000 deaths, serious disabilities a year in U.S.

Annovis Bio delivers candor, but not confidence, on Parkinson’s study

6 phony surgeries that take placebo to the extreme

EMA weighs against approval for Mirati's lung cancer drug

Alabama hospital puts IVF treatments on hold

hotspot

comprehensive

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily coverage and analysis of the biotech sector — by subscribing to STAT+.

entertainment

Malaria cases in Florida and Texas: Here’s what you need to know

The Harvard botanist who searched for psychedelics in the Amazon

Alkermes shareholders re

New chart reveals military’s vast involvement in Operation Warp Speed

Novavax promises a turnaround & Lilly roils the obesity market

What is the Turing Test that determines if computers can think?

In age of alternative facts, a scholarly course on calling out crap

He's a Nobel laureate. Critics say he was misleading on Covid

How to save PrEP access — and even expand it

Trump Organization, Michael Cohen agree to settle million

entertainment

Pfizer's RSV vaccine recommended for approval in Europe

A former Republican legislative candidate has been charged for his role in the US Capitol riot

Readout Newsletter: Alnylam, Celldex, Roche, Zealand Pharma

New chart reveals military’s vast involvement in Operation Warp Speed

Trump Organization, Michael Cohen agree to settle million

Study: Misdiagnosis causes 800,000 deaths, serious disabilities a year in U.S.

explore

hotspot

Wikipedia

Wikipedia